Though previous reports have shown the overexpression of PAK6 in multiple cancers including prostate cancer, breast cancer and in hepatocellular carcinoma, there are limited studies investigating the signaling mechanism of PAK6 in cancer [20, 21]. This evidence concerns the gene PAK6 and breast cancer.